F2R and breast carcinoma: Sara P Y Che reported that tissue factor (TF)-expressing EVs activate quiescent endothelial cells by activating factor X (FXa) and cleavage of protease-activated receptor 1 (PAR-1), inducing secretion of the proinflammatory factor IL-8 in breast cancer cells.